CLINICAL_TRIALS
trial_result
· 2024-02-08
Clinical Trial Update: Examining Bioactivity of PVSRIPO in Invasive Breast Cancer [EARLY_Phase 1]
Summary
Phase 1 clinical trial investigating bioactivity of PVSRIPO in invasive breast cancer has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Istari Oncology, Inc. | Conditions: Invasive Breast Cancer | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2024-02-08